Which Batch Size for Validation and Stability Studies? Process validation for a drug product must be done with commercial scale batches, says Siegfried Schmitt, vice president, Technical at Parexel.

The article provides an answer to the question on whether splitting a commercialize batch of a new drug into sub batches for process validation and stability data requirement purposes is compliant with U.S. and European Union pharmaceutical industry regulations.